Challenges and Strategies for a Thorough Characterization of Antibody Acidic Charge Variants
Sign Up to like & getrecommendations! Published in 2022 at "Bioengineering"
DOI: 10.3390/bioengineering9110641
Abstract: Heterogeneity of therapeutic Monoclonal antibody (mAb) drugs are due to protein variants generated during the manufacturing process. These protein variants can be critical quality attributes (CQAs) depending on their potential impact on drug safety and/or… read more here.
Keywords: charge variants; characterization; thorough characterization; acidic variants ... See more keywords